Abrdn PLC Collegium Pharmaceutical, Inc Transaction History

Abrdn PLC

  • $53.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020
SELL
$13.89 - $25.45 $676,665 - $1.24 Million
-48,716 Closed
0 $0
Q4 2019

Feb 18, 2020
BUY
$10.7 - $22.24 $521,261 - $1.08 Million
48,716 New
48,716 $1 Million
Q2 2018

Aug 09, 2018
SELL
$21.79 - $28.29 $627,137 - $814,214
-28,781 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$18.15 - $29.21 $522,375 - $840,693
28,781 New
28,781 $735,000

Others Institutions Holding COLL

# of Institutions
255
Shares Held
38.6M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.01B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email